acarbose has been researched along with Alloxan Diabetes in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Jiang, H; Jin, Z; Ma, Y; Sun, H; Wang, K; Yu, P; Zhang, M; Zhang, Y; Zheng, H | 1 |
| Li, N; Liu, JP; Shi, YH; Sun, M; Wang, W; Wang, XP; Xie, YD; Xu, XY | 1 |
| Chen, H; Lei, Y; Liu, W; Ma, B; Xu, H; Xu, L; Zhang, X; Zhu, C | 1 |
| Agawane, SB; Ali, AZ; Kumar, KV; Kumbhare, RM; Tiwari, AK | 1 |
| Brindis, F; Bye, R; González-Andrade, M; Mata, R; Rodríguez, R | 1 |
| Bye, R; Escandón-Rivera, S; González-Andrade, M; Linares, E; Mata, R; Navarrete, A | 1 |
| Chen, T; Chen, Z; Jiang, X; Li, X; Wang, M; Wu, J; Zhang, B; Zheng, D | 1 |
| Agrawal, M; Jaiswal, N; Madhur, G; Maurya, CK; Narender, T; Rahuja, N; Srivastava, AK; Tamrakar, AK | 1 |
8 other study(ies) available for acarbose and Alloxan Diabetes
| Article | Year |
|---|---|
New insights into the biological activities of Chrysanthemum morifolium: Natural flavonoids alleviate diabetes by targeting α-glucosidase and the PTP-1B signaling pathway.
Topics: Animals; Cell Line, Tumor; Cholesterol; Chrysanthemum; Cricetulus; Diabetes Mellitus, Experimental; Flavonoids; Glucose; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Male; Mice; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Signal Transduction; Streptozocin; Triglycerides | 2019 |
3,4-Dihydroxyphenethyl nitrate with nitric oxide releasing, antioxidant, hypoglycemic and hypolipidemic effects.
Topics: Administration, Oral; Animals; Antioxidants; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Molecular Structure; Nitrates; Nitric Oxide; Phenylethyl Alcohol; Streptozocin | 2020 |
Novel Hydroxychalcone-Based Dual Inhibitors of Aldose Reductase and α-Glucosidase as Potential Therapeutic Agents against Diabetes Mellitus and Its Complications.
Topics: Aldehyde Reductase; alpha-Glucosidases; Animals; Antioxidants; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glucose; Hypoglycemic Agents; Rats | 2022 |
Reduction in post-prandial hyperglycemic excursion through alpha-glucosidase inhibition by beta-acetamido carbonyl compounds.
Topics: Acarbose; Acetamides; alpha-Glucosidases; Animals; Carbohydrates; Carbon; Diabetes Mellitus, Experimental; Drug Design; Glycoside Hydrolase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Intestines; Models, Chemical; Postprandial Period; Rats | 2008 |
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
Topics: Acarbose; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin; Insulin Secretion; Ligusticum; Medicine, Traditional; Mexico; Mice; Phthalic Anhydrides; Stereoisomerism; Streptozocin | 2011 |
α-glucosidase inhibitors from Brickellia cavanillesii.
Topics: alpha-Glucosidases; Animals; Asteraceae; Benzopyrans; Blood Glucose; Diabetes Mellitus, Experimental; Flavonoids; Glycoside Hydrolase Inhibitors; Inhibitory Concentration 50; Lactones; Male; Mexico; Mice; Sesquiterpenes; Sucrose | 2012 |
Synthesis and anti-hyperglycemic activity of hesperidin derivatives.
Topics: Administration, Oral; alpha-Glucosidases; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Flavanones; Glycoside Hydrolase Inhibitors; Hep G2 Cells; Hesperidin; Humans; Hypoglycemic Agents; Mice; Structure-Activity Relationship | 2012 |
Synthesis of novel triterpene and N-allylated/N-alkylated niacin hybrids as α-glucosidase inhibitors.
Topics: alpha-Glucosidases; Animals; Blood Glucose; Circular Dichroism; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Kinetics; Models, Chemical; Molecular Structure; Niacin; Rats; Treatment Outcome; Triterpenes | 2013 |